Literature DB >> 21952582

Performance of a colorectal cancer screening protocol in an economically and medically underserved population.

Shan-Rong Cai1, Su-Zhan Zhang, Hong-Hong Zhu, Yan-Qin Huang, Qi-Rong Li, Xin-Yuan Ma, Kai-Yan Yao, Shu Zheng.   

Abstract

The performance of combining fecal immunochemical tests (FITs) and a high-risk factor questionnaire (HRFQ) in colorectal cancer (CRC) screening in economically and medically underserved populations is uncertain. This study investigated the performance of a CRC screening protocol of combining FITs and an HRFQ as primary screening methods in a rural Chinese population. A CRC mass screening was conducted using FITs and an HRFQ as the first and colonoscopy as the second stage of screening in Jiashan, 2007-2009. The target population was 31,963 residents in three communities. The compliance was 84.7% for HRFQ, 76.4% for FITs, and 78.7% for colonoscopy. The detected rates of cancer, adenoma, nonadenomatous polyps, and advanced neoplasm were 2.7%, 14.8%, 5.9%, and 8.9% by FITs, which were higher than those by HRFQ (0.5%, 9.2%, 4.8%, and 3.8%, respectively). There was no significant difference in detected rate for nonadenomatous polyps between FITs and HRFQ. A total of 41.2% adenomas, 53.2% nonadenomatous polyps, and 29.8% advanced neoplasms were detected by HRFQ but missed by FITs. Positive predictive value of the screening protocol of combining FITs and HRFQ for advanced neoplasm was 5.7%, which was higher than FITs alone. Men had a higher prevalence of advanced neoplasm than women. Results indicate that combining FITs and HRFQ as primary screening methods is an efficient CRC screening strategy in economically and medically underserved populations.

Entities:  

Mesh:

Year:  2011        PMID: 21952582     DOI: 10.1158/1940-6207.CAPR-10-0377

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  9 in total

1.  Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening.

Authors:  Wen Meng; Hong-Hong Zhu; Ze-Feng Xu; Shan-Rong Cai; Qi Dong; Qiang-Rong Pan; Shu Zheng; Su-Zhan Zhang
Journal:  World J Gastrointest Oncol       Date:  2012-06-15

2.  Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study.

Authors:  Mingqing Zhang; Lizhong Zhao; Yongdan Zhang; Haoren Jing; Lianbo Wei; Zhixuan Li; Haixiang Zhang; Yong Zhang; Siwei Zhu; Shiwu Zhang; Xipeng Zhang
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

3.  Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy.

Authors:  Yi Liao; Senmao Li; Chunyu Chen; Xuan He; Feng Lin; Jianping Wang; Zuli Yang; Ping Lan
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-09-05

4.  Mass screening for colorectal cancer in a population of two million older adults in Guangzhou, China.

Authors:  Guozhen Lin; Zhiqiang Feng; Huazhang Liu; Yan Li; Yuqiang Nie; Yingru Liang; Ke Li
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

5.  Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China.

Authors:  Ji-Bin Li; Zhi-Yu Qiu; Yu-Xiang Deng; Yin Li; Zhuo-Chen Lin; Yan-Ping Wu; Fan Weng; Huan Tian; Qing-Jian Ou; Cheng-Hua Gong; Zhi-Zhong Pan; De-Sen Wan; Jian-Hong Peng; Yu-Jing Fang
Journal:  Discov Oncol       Date:  2022-01-08

6.  The implementation of colorectal cancer screening interventions in low-and middle-income countries: a scoping review.

Authors:  Désirée Schliemann; Kogila Ramanathan; Nicholas Matovu; Ciaran O'Neill; Frank Kee; Tin Tin Su; Michael Donnelly
Journal:  BMC Cancer       Date:  2021-10-19       Impact factor: 4.430

7.  Modifiable lifestyle factors have a larger contribution to colorectal neoplasms than family history.

Authors:  Shuyuan Wang; Zhen Yuan; Yuqi Wang; Xuanzhu Zhao; Weifeng Gao; Hongzhou Li; Yuanshun Zhao; Zili Zhang; Shuiqing Liang; Zhaoce Liu; Qinghuai Zhang; Hong Ma; Xipeng Zhang; Wei Cui; Chunze Zhang
Journal:  BMC Cancer       Date:  2022-10-07       Impact factor: 4.638

8.  An early report of a screening program for colorectal cancer in Guangzhou, China.

Authors:  Yujing Fang; Binyi Xiao; Jianhong Peng; Huan Tian; Fulong Wang; Lingheng Kong; Shiyong Lin; Jibin Li; Qiying Su; Kunwu Luo; Meixian Ye; Qingjian Ou; Wenhua Fan; Cong Li; Junzhong Lin; Rongxin Zhang; Wenhao Zhou; Liren Li; Gong Chen; Zhenhai Lu; Xiaojun Wu; Peirong Ding; Meichun Zheng; Xia Yang; Zhizhong Pan; Desen Wan
Journal:  Ann Transl Med       Date:  2019-11

9.  Cost-Effectiveness between Double and Single Fecal Immunochemical Test(s) in a Mass Colorectal Cancer Screening.

Authors:  Shan-Rong Cai; Hong-Hong Zhu; Yan-Qin Huang; Qi-Long Li; Xin-Yuan Ma; Su-Zhan Zhang; Shu Zheng
Journal:  Biomed Res Int       Date:  2016-04-07       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.